A prospective, randomised, partially-blinded, placebo-controlled, phase III, multicentre trial to assess safety, tolerability and imunogenicity of liquid influenza virus vaccine, trivalent, types A & B, live cold-adapted (liquid CAIV-T) administered concomitantly with live, attenuated, poliovirus vaccine in healthy children
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Breiman, Robert F. | - |
| dc.contributor.author | Brooks, Abdullah | - |
| dc.contributor.author | Naheed, Aliya | - |
| dc.date.accessioned | 2014-02-19T09:00:17Z | - |
| dc.date.available | 2014-02-19T09:00:17Z | - |
| dc.date.issued | 2001 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/4924 | - |
| dc.format.extent | 1996675 bytes | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | ICDDRB Research Protocol | en |
| dc.relation.ispartofseries | no. 2001-011 | en |
| dc.subject | Clinical Protocols | en |
| dc.subject | Vaccination | en |
| dc.subject | Child | en |
| dc.subject | Prospective Studies | en |
| dc.title | A prospective, randomised, partially-blinded, placebo-controlled, phase III, multicentre trial to assess safety, tolerability and imunogenicity of liquid influenza virus vaccine, trivalent, types A & B, live cold-adapted (liquid CAIV-T) administered concomitantly with live, attenuated, poliovirus vaccine in healthy children | en |
| dc.type | Other | en |
| Appears in Collections: | Public health sciences research protocols | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| ICDDRBProtocol-2001-011.pdf | 1.95 MB | Adobe PDF | View/Open |
This item is protected by original copyright |